Gemina Laboratories Ltd. announced a non-brokered private placement of up to 1,666,667 units at a price of CAD 0.60 per share for gross proceeds up to CAD 1,000,000 on June 23, 2022. Each unit will consist of one common share and one share purchase warrant. Each warrant will be exercisable to acquire one share at an exercise price of CAD 0.80 per share for a period of 60 months following the Closing Date, subject to acceleration in certain circumstances.

All securities issued as part of the transaction will be subject to a hold period four months.